BCL2L11 and cancer: High PKM2 expression predicts poor prognosis and inhibits apoptosis by promoting Bim degradation, while PKM2 knockdown stabilizes Bim and induces apoptosis, indicating that its cancer-promoting effect depends on its interaction with apoptotic regulators (21).